MentionFox
Home › funding signals › PolyPid Ltd.
Form D · on the record

PolyPid Ltd. — $26.69M Form D filing, June 2025

PolyPid Ltd. filed a Form D with the Securities and Exchange Commission on 2025-06-23.

PolyPid Ltd. filed a Form D notice of an exempt securities offering with the SEC on June 23, 2025. The filing reports $26.69M sold. Its industry group is Biotechnology. It names Dikla Czaczkes Akselbrad (Executive Officer), Dalit Hazan (Executive Officer), Ori Warshavsky (Executive Officer) (SEC Form D, June 23, 2025).

3 more Biotechnology raises in Israel within 90 days ↓

Is this your company?

Key facts

Run the free check on PolyPid Ltd. →

Sell to companies like PolyPid Ltd? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

PolyPid Ltd.

New Form D on file · 2025-06-23 · the record

$26.69M
raise on the record
D
filing
20
investors in
ISRAEL
based
Open the record →

What the record says

FilingForm D
Filed2025-06-23
Industry groupBiotechnology
Entity typeCorporation
Incorporated inISRAEL
BasedPETACH TIKVA, ISRAEL
CIK1611842
Accession0001213900-25-056691

Pitching, partnering or investing alongside them? See who really runs and owns PolyPid Ltd.

Free to see. No signup.

Keep reading

More on the people and the money behind PolyPid Ltd., from the filings we hold.

More raises like this

Biotechnology raises by companies based in Israel, filed within 90 days of this one, largest first.

What do you want to do with PolyPid Ltd.?

Get the full cited report on PolyPid Ltd.

What the filing shows about PolyPid Ltd.

  • 20 investors had already put money in when it filed.
  • The filing names 12 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on PolyPid Ltd.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

Who the filing names, and in what role

The filing gives PolyPid Ltd.'s address as 18 Hasivim Street, Petach Tikva, L3 495376.

What the filing says

  • Offered: $26,692,799. Sold: $26,692,799. Left to sell: nothing, all of it is sold. (filing)
  • Investors: 20 had already invested. (filing)
  • Date of first sale: June 16, 2025. (filing)
  • Types of securities: Equity; Options, warrants or other rights to acquire another security; Securities to be acquired on exercise of an option, warrant or other right. (filing)
  • Item 16: the filing reports that none of the proceeds goes to executive officers, directors or promoters. (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on PolyPid Ltd. See pricing

Is PolyPid Ltd. a real, registered company?

PolyPid Ltd. is a registered filer with the SEC (CIK 1611842) and has filed since 2024-01-22. 4 filings are on record, the latest on 2025-06-23.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs PolyPid Ltd.?

PolyPid Ltd.'s Form D of 2025-06-23 names Dikla Czaczkes Akselbrad, Dalit Hazan, Ori Warshavsky and 9 more as its officers, directors or promoters.

How much has PolyPid Ltd. raised?

Its new offerings report $90.40M sold across 4 offerings, as its own filings state.

Filing history · 4 filings on this registrant
Form D · 2024-01-22 · $35.01MForm D · 2024-08-12 · $14.20MForm D · 2025-01-02 · $14.50MForm D · 2025-06-23 · $26.69M · this page 2024-01-22 2025-06-23

Each marker is one filing. The larger marker is the filing this page is about.

Biotechnology · by week

Trailing twelve months. 769 filings in Biotechnology, totalled by week.

Want the whole picture on PolyPid Ltd.?

What the filing shows about PolyPid Ltd.

  • 20 investors had already put money in when it filed.
  • The filing names 12 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on PolyPid Ltd.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on PolyPid Ltd. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind PolyPid Ltd.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.

Sourced from the filing index on sec.gov.

RSS

Tools for this story

Each opens in a new tab, filled in for PolyPid Ltd.. With no account yet, you sign up free and land on the result.

More on PolyPid Ltd.

Share this page

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

PolyPid Ltd.: Raised $26.69M, Form D filed 2025-06-23
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/polypid-ltd-form-d-25000001
Last updated 2026-11-01
Primary record: SEC filing 1 · SEC filing 2
PolyPid Ltd. raised $26.69M — SEC Form D filing, June 2025. MentionFox, 2026-11-01. https://mentionfox.com/funding/polypid-ltd-form-d-25000001